Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Lantheus Holdings, Inc. | Director | Common Stock | 28.6K | $2.25M | $78.50 | May 28, 2024 | Direct |
IRONWOOD PHARMACEUTICALS INC | Director | Class A Common Stock | 164K | $1.03M | $6.29 | Jun 18, 2024 | Direct |
Evelo Biosciences, Inc. | Director | Stock Option (Right to Buy) | 20K | Jun 8, 2023 | Direct | ||
Lantheus Holdings, Inc. | Director | Stock Option (right to buy) | 4.85K | May 9, 2024 | Direct | ||
AERIE PHARMACEUTICALS INC | Director | Common Stock | 0 | $15.25 | Nov 21, 2022 | Direct | |
AERIE PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | $9.14 | Nov 21, 2022 | Direct |